Title: 
Official Title: To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short title
 This Act may be cited as the Treatment Continuity Act of 2025.

Section 2:
2.Priority substance use disorder and serious mental illness treatment needs of regional and national significance 
(a)In generalSection 509 of the Public Health Service Act (42 U.S.C. 290bb–2) is amended— (1)in the section heading, by inserting AND SERIOUS MENTAL ILLNESS after SUBSTANCE USE DISORDER; 
(2)in subsection (a)— (A)in the matter preceding paragraph (1), by inserting and serious mental illness after substance use disorder; and 
(B)by striking paragraphs (1) through (3) and inserting the following:  (1)access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness; 
(2)lab testing and supportive counseling for substance use disorder and serious mental illness; and (3)training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling.; 
(3)in subsection (b)— (A)in the subsection heading, by inserting and Serious Mental Illness after Substance Use Disorder; and 
(B)in paragraphs (1) and (2), by inserting and serious mental illness after substance use disorder; (4)by striking subsections (d) and (e) and inserting the following: 
 
(d)Annual report to CongressNot later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment.; and (5)by redesignating subsection (f) as subsection (e). 
(b)ApplicabilityThe amendments made by this section shall apply to grants made under section 509 of the Public Health Service Act after the date of the enactment of this Act.


================================================================================

Raw Text:
119 HR 4030 IH: Treatment Continuity Act of 2025
U.S. House of Representatives
2025-06-17
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 4030IN THE HOUSE OF REPRESENTATIVESJune 17, 2025Mr. Dunn of Florida (for himself, Mr. Soto, and Mr. Bean of Florida) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes. 
1.Short title
 This Act may be cited as the Treatment Continuity Act of 2025. 
2.Priority substance use disorder and serious mental illness treatment needs of regional and national significance 
(a)In generalSection 509 of the Public Health Service Act (42 U.S.C. 290bb–2) is amended— (1)in the section heading, by inserting AND SERIOUS MENTAL ILLNESS after SUBSTANCE USE DISORDER; 
(2)in subsection (a)— (A)in the matter preceding paragraph (1), by inserting and serious mental illness after substance use disorder; and 
(B)by striking paragraphs (1) through (3) and inserting the following:  (1)access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness; 
(2)lab testing and supportive counseling for substance use disorder and serious mental illness; and (3)training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling.; 
(3)in subsection (b)— (A)in the subsection heading, by inserting and Serious Mental Illness after Substance Use Disorder; and 
(B)in paragraphs (1) and (2), by inserting and serious mental illness after substance use disorder; (4)by striking subsections (d) and (e) and inserting the following: 
 
(d)Annual report to CongressNot later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment.; and (5)by redesignating subsection (f) as subsection (e). 
(b)ApplicabilityThe amendments made by this section shall apply to grants made under section 509 of the Public Health Service Act after the date of the enactment of this Act.